%PDF-1.3
%
7 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
10 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
11 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 130>>stream
x1 SQ0M `iRC*-ߨ9$Jp8Z$]Re
ŻT:k;J)mؘOt?(qؘgUnuo^H(
endstream
endobj
13 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W Unicode
2018-10-22T20:58:30-07:00
2017-11-22T10:45:27+05:30
application/pdf
ACT-2017-29135-eya-Yarnell_3P 246..255
uuid:d8232ab7-ff93-40fd-9fa5-667569c73b8f
uuid:2fc30390-2e7d-49b7-8bde-cafbb3ab8e5b
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 Bi y,
endstream
endobj
28 0 obj
<>stream
x+ |
endstream
endobj
29 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
30 0 obj
<>stream
x+ |
endstream
endobj
31 0 obj
<>stream
xS**T0T0 Bi y+
endstream
endobj
32 0 obj
<>stream
x+ |
endstream
endobj
33 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
35 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
9.9626 0 0 9.9626 35.8866 265.0393 Tm
0 0 0 rg
0 Tc
0 Tw
[(dose)-358.8(unst)-7(ated\))-364.9(and)]TJ
/F4 1 Tf
8.0464 0 TD
[(Geraniu)-9.3(m)]TJ
/F3 1 Tf
4.4159 0 TD
[(spp.)-362.4(\(cranes)-10.1(bill,)-358.8(l)]TJ
/F5 1 Tf
7.1075 .0228 TD
()Tj
/F3 1 Tf
.0285 -.0228 TD
[(ao)-361.8(gua)]TJ
2.373 0 TD
.054 Tc
[(`n)-305.3(c)]TJ
/F5 1 Tf
1.6673 .0228 TD
0 Tc
()Tj
/F3 1 Tf
.0228 -.0228 TD
(ao\))Tj
-23.6613 -1.2007 TD
[(aerial)-347.5(parts)-347.3(relieved)-349(chem)-10.2(otherapy)-8.7(-induced)-350.2(neuropat)-8.7(hy)-343(com-)]TJ
T*
[(pared)-282.5(to)-283.1(no)-280.4(treat)-9.2(ment.)]TJ
7.4718 0 0 6.641 124.7244 245.5369 Tm
(11)Tj
9.9626 0 0 9.9626 44.8441 229.1527 Tm
[(The)-487.6(aconite)-10.5(-containi)-9.3(ng)-485.2(Japanese)-493.6(formula)-489.7(gosha-)-9.5(jinki-gan)]TJ
-.8991 -1.2007 TD
[(\(which)-237(is)-227.4(based)-236.2(on)-234.8(the)-228.8(Chines)-9.3(e)-230.2(formul)-9.1(a)-230.2(niu)]TJ
16.8611 -.0114 TD
()Tj
.6487 .0114 TD
(ch)Tj
/F5 1 Tf
.9219 .0284 TD
()Tj
/F3 1 Tf
.0285 -.0284 TD
[(e)-230.2(she)]TJ
1.6275 0 TD
.0483 Tc
[(`n)-185.8(q)48.3()]TJ
1.5934 0 TD
.2019 Tc
[(`w)201.9(a)]TJ
1.3145 0 TD
.054 Tc
[(n)-174.4(o)54(r)]TJ
-22.9955 -1.2007 TD
0 Tc
[(Life)-254.1(Preservi)-11.1(ng)-251.9(Kidney)-257.7(Qi)-252.9(Pill,)-249.9(devel)-10.1(oped)-255.2(in)-249(1253)-253.4(CE)-256.4(by)-251.9(Ya)]TJ
24.0596 0 TD
.054 Tc
(n)Tj
-24.0596 -1.2007 TD
0 Tc
(Yo)Tj
.8024 0 TD
[(`)-82.4(ng-H)-9(e)]TJ
2.538 0 TD
[()-480.7(i)0(n)-436.8(his)-433(b)-6.5(ook)]TJ
/F4 1 Tf
6.0718 0 TD
(J)Tj
.4268 .0114 TD
(`)Tj
.7341 -.0114 TD
(Sh)Tj
/F5 1 Tf
.9788 .0057 TD
()Tj
/F4 1 Tf
.0228 -.0057 TD
[(eng)-436.6(F)]TJ
/F5 1 Tf
2.4982 .0057 TD
()Tj
/F4 1 Tf
0 -.0057 TD
(ang)Tj
/F3 1 Tf
1.9348 0 TD
([)Tj
/F4 1 Tf
.3357 0 TD
[(Form)-8(ulas)-433.8(to)-436.8(Aid)-437.3(the)]TJ
-16.3433 -1.2007 TD
(Living)Tj
/F3 1 Tf
2.5664 0 TD
[(]\))-443.6(bear)-8.6(s)-440.1(clos)-8.8(er)-443.5(scru)-8(tiny,)-447.1(as)-442.7(it)-445.2(has)-449.1(been)-450.5(studied)-452(fairly)]TJ
-2.5664 -1.195 TD
[(extensivel)-11.1(y.)-223.1(Its)-224.5(ingredient)-10.1(s)-218.2(are)-229.8(outlined)-226.7(in)-220.5(Tab)-9.6(le)-222.3(1.)-223.1(Despite)-230.1(the)]TJ
0 -1.2007 TD
[(relative)-10.3(ly)-391.2(low)-390.3(amo)-7.6(unt)-392(of)-390.5(aconi)-10.1(te)-393(in)-391.3(the)-393.8(formula,)-399(it)-394(is)-392.4(a)-389.5(key)]TJ
T*
[(component)-11(.)-370.3(I)0(n)-379.1(one)-374(rando)-7.6(mized)-383.6(but)-374.9(open)-380.4(trial)-380.1(of)-373.4(29)-377.1(patients)]TJ
T*
[(undergoin)-7.7(g)-547.1(chem)-10.2(otherapy)-555(with)-553.1(paclitaxe)-10.9(l)-549.8(and)-550.4(carb)-8.6(oplatin,)]TJ
T*
[(gosha-jinki)-10.2(-gan)-615.7(granu)-7.6(les)-616.9(2.5)-166.9(g)-615.3(t.i.d.)-617.8(and)-613(methyl)-9.7(cobalam)-11.3(in)]TJ
T*
(500)Tj
/F9 1 Tf
1.6673 0 TD
(m)Tj
/F3 1 Tf
.552 0 TD
[(g)-359.3(t.i.d.)-361.8(were)-365.3(super)-8.8(ior)-359.8(to)-357.1(methyl)-9.7(cobalam)-11.3(in)-357.1(alon)-7.6(e)-355.4(a)0(t)-364.6(pre-)]TJ
-2.2193 -1.2007 TD
[(venting)-246(progress)-8.5(ion)-244.1(of)-236.8(periph)-11.1(eral)-244.7(neuropat)-8.7(hy.)]TJ
7.4718 0 0 6.641 218.5511 102.0472 Tm
(12)Tj
9.9626 0 0 9.9626 228.4157 97.6252 Tm
[(A)-238(simi)-7.6(lar)-242.1(trial)]TJ
-19.3251 -1.2007 TD
[(involving)-555.8(60)-547.8(Japan)-8.6(ese)-553.3(breast)-554.7(cancer)-554.3(patient)-11.5(s)-548.3(treated)-553.1(wi)-8.2(th)]TJ
0 -1.195 TD
[(docetaxe)-10.3(l)-327.9(found)-330.2(that)-329(neuro)-7.6(pathy)-332.7(occurred)-334.1(in)-328.7(40)-7.2(%)-327.9(o)0(f)-327.9(patients)]TJ
0 -1.2007 TD
.0157 Tc
[(treated)-576.9(w)-6.1(ith)-582.6(gosha-jinki-gan)]TJ
12.9631 0 TD
.0149 Tc
[(and)-583.4(m)-.8(et)-5.7(hylc)-4.7(obal)-5.7(amin)-583.4(c)-4.7(o)2.8(m-)]TJ
-12.9631 -1.2007 TD
0 Tc
[(p)-12.2(a)-19.6(r)-14.1(e)-19.6(d)-199.9(t)-14.9(o)-205.6(89%)-187.1(of)-191.3(those)-191.7(taking)-188.3(methyl)-9.7(cobalam)-11.3(in)-186.4(only.)]TJ
7.4718 0 0 6.641 242.7023 54.2551 Tm
(13)Tj
9.9626 0 0 9.9626 251.9999 49.833 Tm
[(A)-186.8(lar)-8.8(ger)]TJ
6.1572 66.0161 TD
[(trial)-323.2(rando)-7.6(mized)-321(45)-325.9(Japanese)-328.6(colon)-321.3(cance)-11(r)-321.4(patients)-326.4(to)-323(gosha-)]TJ
0 -1.2007 TD
[(jinki-gan)-292.1(granules)-294.4(2.5)-166.9(g)-285.3(t.i.d.)-287.8(or)-288(no)-286.1(additional)-289.7(treat)-9.2(ment)-290(while)]TJ
T*
[(un)21.2(de)13.8(rg)19.3(oi)18.5(ng)-166.6(ox)15.5(al)16.7(i)13.5(p)0(l)18.5(a)0(t)16.7(i)0(n)18.5(,)-176.8(u)16.3(or)19.3(ou)15.5(ra)17.5(ci)16.7(l,)-168.9(an)19.5(d)-177.2(f)0(o)19.3(l)0(i)15.7(n)0(i)18.5(c)-179(ac)17.7(id)-169.3(\(F)20(OL)17.5(FO)12.4(X)12.4(\))]TJ
T*
[(che)11.2(mot)14.2(her)11(apy)13(.)]TJ
7.4718 0 0 6.641 371.9054 676.0628 Tm
(14)Tj
9.9626 0 0 9.9626 385.6818 671.6407 Tm
[(No)-637.1(pat)15.9(ien)10.2(t)-635.2(rec)9.2(eiv)10.2(ing)-625.3(gosh)12.8(a-j)14(ink)12(i-)10.8(gan)-630(de-)]TJ
-7.2611 -1.2007 TD
[(vel)15.9(oped)-260.9(gra)11(de)-270.8(3)-268.2(o)0(r)-271(h)0(i)12.8(gher)-262.9(neu)13(rop)12.8(ath)10.2(y)-268.2(comp)14.4(are)9.2(d)-273.9(t)0(o)-266.1(12%)-261.1(in)-271.7(th)12.8(e)]TJ
T*
[(FOL)11.8(FOX-)16.4(onl)12(y)-194.3(gro)12.8(up)-189.3(af)11.8(ter)-185.2(10)-189.3(cou)13(rse)9.8(s.)-184.4(Afte)9.3(r)-190.5(2)0(0)-183.6(cour)10.3(se)12.6(s,)-190.1(33%)-187.1(in)]TJ
0 -1.195 TD
[(th)12.8(e)-412.3(gosh)12.8(a-j)13.9(ink)12(i-ga)13.2(n)-410.5(gro)12.8(up)-405.6(ver)11(sus)-403(75%)-403.4(in)-408.3(the)-405.2(FO)12.4(LFOX)12.8(-on)12.8(ly)]TJ
0 -1.2007 TD
[(gro)12.8(up)-297.4(had)-300(suc)11.8(h)-308.1(s)0(e)12.6(ver)11(e)-309.8(neu)13(rop)12.8(ath)10.2(y.)-297.1(Ther)10.4(e)-304.2(w)0(e)9.8(r)0(e)-306.9(n)0(o)-297.4(diff)18.7(ere)9.2(nce)11.2(s)]TJ
T*
[(bet)15.9(ween)-204(the)-206(gro)12.8(ups)-208.3(in)-209.2(ter)14(ms)-211.1(of)-208.4(tumo)13.4(r)-213.3(res)9.8(pon)14.8(se)-209.4(or)-208.4(oth)12(er)-210.2(adve)10.4(rs)12.4(e)]TJ
T*
[(ef)11.8(fec)9.2(ts,)-387.1(con)13(rmi)17.9(ng)-388.5(tha)10.2(t)-396.2(t)0(h)12.8(e)-395.2(for)10.8(mul)14.2(a)-395.2(doe)13(s)-394.6(not)-386.3(wor)14.6(k)-393.4(b)0(y)-388.5(inte)12.4(r-)]TJ
T*
[(fe)11.8(ring)-263.9(wit)11(h)-279.6(t)0(h)12.8(e)-281.4(th)12.8(era)9.2(peu)13(tic)-271.4(ef)11.8(fec)9.2(ts)-272.9(of)-271(FOL)11.8(FOX.)]TJ
.8991 -1.2007 TD
.0114 Tc
[(The)-628.5()0(rst)-629.5(d)-.7(o)4.9(uble-blind)4.9(,)-632(rand)4.9(omized,)-626.3(p)-.7(lacebo-con)4.9(t)-3.5(rolled)]TJ
-.8991 -1.2007 TD
.0112 Tc
[(trial)-293.9(o)4.7(f)-293.1(gosha-jin)4.7(ki-gan)-291.2(granul)]TJ
12.4851 0 TD
.0113 Tc
[(es)-286.6(2.5)-165.9(g)-291.1(t.i.d.)-290.7(involved)-291.1(89)-285.4(Jap-)]TJ
-12.4851 -1.2007 TD
.0123 Tc
[(a)4.1(n).2(es)4.7(e)-747.1(can)5.8(cer)-747.3(p)5.8(a)-1.6(tie)4.1(n).2(ts)-746.5(unde)4.1(r)-1.8(go)5.8(in)5.8(g)-751(o)5.8(xaliplatin)5.8(-)-1.8(co)5.8(ntaining)]TJ
0 -1.195 TD
.0102 Tc
[(che)-3.7(m).2(othe)-3.7(ra)-3.7(py.)]TJ
7.4718 0 0 6.641 373.8896 544.592 Tm
.016 Tc
(15)Tj
9.9626 0 0 9.9626 385.7952 540.1699 Tm
.0131 Tc
[(Gr)4.7(ade)-421.9(2)-425.8(and)-425.8(3)-420.2(per)4.7(i)-1.8(p)6.6(h)1(er)4.7(al)-422.9(neu)6.6(r)-1(op)6.6(athy)-425.8(oc)4.9(-)]TJ
-7.2725 -1.2007 TD
.0125 Tc
[(c)4.3(u).4(rr)4.1(ed)-380.9(s)4.9(i)-2.4(g)6(n).4(ican)6(tly)-380.9(l)3.3(ess)-376.4(o).4(ften)-380.9(in)-380.9(the)-382.7(gos)4.8(ha-)4.1(j)3.3(in)6(ki-ga)4.2(n)-380.9(gro)6(u).4(p)]TJ
T*
.0106 Tc
[(compared)-269(to)-274.7(the)-270.8(p)-1.5(lacebo)-274.7(g)4.1(roup.)-268.6(G)-5.5(iven)-274.7(the)-270.8(p)-1.5(osit)-4.3(ive)-270.8(r)2.2(esult)-4.3(s)-270.2(of)]TJ
T*
[(so)-354.4(many)-354.4(prior)-356.3(t)1.4(rials,)-354(it)-357.1(was)-355.6(q)4.1(ui)]TJ
13.1167 0 TD
.0139 Tc
[(te)-347.2(sur)5.5(p)1.8(r)5.5(i)-1(s)6.3(i)-1(n)7.4(g)-351.1(th)7.4(at)-348.1(the)-347.2(l)-1(a)5.7(r)-.2(g)7.4(e)0(st)]TJ
-13.1167 -1.2007 TD
.0123 Tc
[(d)5.8(ouble-)3.9(b).1(lin)5.8(d).2(,)-227.1(r)-1.8(an)5.8(domized)-227.5(clinical)-224.5(tr)3.9(ial)-230.2(t)3.1(o)-227.5(d).2(ate)-229.3(h).2(ad)-227.5(a)-229.3(d).2(iff)3.9(e)-1.6(r)3.9(e)-1.6(nt)]TJ
T*
.0112 Tc
[(o)4.7(u)-.9(tcome.)-398.9(In)-405(this,)-404.6(1)4.7(42)-399.3(Japane)]TJ
12.3257 0 TD
.0126 Tc
[(se)-399.7(c)4.4(o).5(lon)-397.9(can)6.1(cer)-394.2(patients)-399.1(w)2.2(er)4.2(e)]TJ
-12.3257 -1.2007 TD
.0115 Tc
[(rand)5(omized)-211.2(to)-211.2(gosha-jink)5(i)-3.4(-gan)-211.2(granules)-212.4(2)5(.)-.3(5)-165.7(g)-211.2(t.i.)5.4(d.)-210.8(or)-207.5(placebo)]TJ
T*
.0084 Tc
[(al)-6.5(on)-3.7(g)-424.9(w)-2(it)-6.5(h)-419.2(F)-3(O)-7.7(L)-3.6(FOX)-423.1(c)-5.5(he)-5.5(mo)-3.7(th)-3.8(e)-5.5(r)0(a)-5.5(p)-3.8(y.)]TJ
7.4718 0 0 6.641 466.6393 460.9132 Tm
.016 Tc
(16)Tj
9.9626 0 0 9.9626 478.5447 456.4345 Tm
.0131 Tc
[(An)-414.5(int)3.9(e)4.9(ri)3.9(m)-418(a)-.8(na)4.9(ly)6.6(si)3.9(s)]TJ
-16.5823 -1.195 TD
.0114 Tc
[(found)-319.4(t)2.2(hat)-322.2(n)-.7(europathy)-319.4(w)1(as)-314.9(actually)-319.4(s)-1.9(ign)4.9(i)-3.5(cantly)-319.4(mo)4.9(re)-321.2(com-)]TJ
0 -1.2007 TD
.0117 Tc
[(mon)-364.6(i)2.5(n)-364.6(t)-3.2(h)5.2(e)-366.4(gosh)5.2(a-jinki-gan)-364.6(group)-364.6(c)3.5(ompared)-364.6(t)2.5(o)-364.6(t)-3.2(h)5.2(e)-366.4(placebo)]TJ
T*
.0104 Tc
[(group,)-399.7(and)-400.1(t)-4.5(he)-401.9(trial)-397.2(w)0(as)-395.6(halte)]TJ
12.6558 0 TD
.0102 Tc
[(d)-400.3(\()1.8(it)-403.1(was)-395.8(i)-4.7(ni)-4.7(tially)-400.3(planned)-400.3(t)1(o)]TJ
-12.6558 -1.2007 TD
.0137 Tc
[(e)5.5(n)1.6(ro)7.2(ll)-376.8(310)-379.7(pa)5.5(ti)4.5(en)7.2(ts)-380.9(i)4.5(n)-379.7(t)4.5(h)1.6(e)-381.5(t)-1.2(r)5.3(i)4.5(al)]TJ
12.8094 0 TD
.0116 Tc
[(\).)-381.4(The)-383.6(a)3.4(uthors)-383(s)-1.7(peculate)-383.6(that)]TJ
-12.8094 -1.2007 TD
.0118 Tc
[(g)5.3(o)-.3(sha-jinki-g)5.3(an)-455.6(was)-456.8(m)1.8(ostly)-455.6(effe)]TJ
13.8053 0 TD
.0116 Tc
[(ctiv)5.1(e)-457.6(a)-2.3(t)-458.6(s)3.9(uppressing)-455.8(acute)]TJ
-13.8053 -1.2007 TD
.0111 Tc
[(n)4.6(e)-2.8(uropathy)-234.4(i)-3.8(n)4.6(duced)-240.1(by)-240.1(o)4.6(x)-1(alipla)]TJ
12.9346 0 TD
.0107 Tc
[(tin,)-240.1(but)-237.5(ei)-4.2(ther)-242.4(it)-237.5(did)-240.4(n)-1.5(ot)-237.5(affect)]TJ
-12.9346 -1.2007 TD
.011 Tc
[(chro)4.5(nic)-441.1(n)-1.1(euro)4.5(pathy)-439.3(from)-442.8(c)2.8(ontinuou)4.5(s)-440.5(u)-1.1(se)-441.1(or)-435.6(it)-442.1(allowed)-439.3(f)-3.1(o)4.5(r)]TJ
T*
.0124 Tc
[(h)5.9(i)-2.5(gh)5.9(er)-445.6(dose)-445.4(i)-2.5(n)5.9(t)-2.5(e)4.2(n).3(sity,)-448.9(t)3.2(hus)-444.8(cau)5.9(sing)-449.3(mor)4(e)-451.1(ch)5.9(ron)5.9(i)-2.5(c)-445.4(d).3(amage)4.2(.)]TJ
0 -1.195 TD
.0113 Tc
[(They)-262.6(intend)-256.9(t)-3.6(o)-256.9(do)-262.6(a)-264.4()-.1(ve-year)-264.6(f)2.9(oll)-3.6(o)4.8(w)-4.8(-)2.9(up)-262.6(of)-258.9(treated)-262.6(p)4.8(ati)-3.6(e)3.1(nts)-263.8(t)2.1(o)]TJ
0 -1.2007 TD
.0099 Tc
[(try)-269.7(t).7(o)-269.7(d)-2.2(et)-5(er)-4.2(mine)-271.5(any)-269.7(l).7(ong-)-4.2(te)-4(rm)-267.5(e)-4(f)1.5(f)-4.2(e)1.7(c)-4(t).7(s)-270.9(o)3.4(f)-271.7(t).7(he)-265.8(he)-4(rbal)-266.8(f)-4.2(o)-2.2(rmul)-5(a.)]TJ
T*
.0115 Tc
[(Based)-313.6(o)5(n)-313.6(t)-3.4(hese)-315.4(results,)-313.2(gosha-jink)5(i)-3.4(-gan)-313.6(shou)5(ld)-313.6(o)5(n)-.6(ly)-307.9(be)-315.4(used)]TJ
T*
.0104 Tc
[(for)-288.2(p)-1.7(atients)-287.5(w)-5.7(ith)-292(unrem)-5.3(itt)-4.5(ing)-286.3(n)-1.7(europathy)-292(t)1.2(hat)-289(n)3.9(ot)-4.5(hi)-4.5(ng)-292(else)-288.1(is)]TJ
T*
.0117 Tc
[(h)5.2(e)-2.2(lping.)-483.8(It)-486.9(sh)5.2(ould)-484.1(b)-.4(e)-485.9(c)3.5(lo)5.2(sely)-484.1(monitored,)-483.8(an)5.2(d)-484.1(t)-3.2(h)5.2(e)-485.9(fo)5.2(rmula)]TJ
T*
.0115 Tc
[(should)-370.5(b)-.6(e)-372.3(s)3.9(topped)-370.5(if)-366.8(th)5(ere)-366.6(i)-3.4(s)-366(w)-4.6(orsening.)-370.1(U)1.1(se)-372.3(o)5(f)-372.5(aconite)-372.3(by)]TJ
T*
.0112 Tc
[(itself)-304.5(m)1.2(ight)-299.6(also)-302.6(be)-304.3(considered)]TJ
13.0712 0 TD
.0103 Tc
[(in)-303.5(pat)-4.6(i)1.1(ent)-4.6(s)-304.6(with)-309.1(chemothera-)]TJ
-13.0712 -1.2007 TD
.0123 Tc
[(p)5.8(y).2(-indu)5.8(ced)-278.7(p)5.8(e)-1.6(riph)5.8(eral)-275.8(neuropath)5.8(y.)]TJ
.8991 -1.195 TD
0 Tc
[(Diabeti)-9.7(c)-304.2(neuropat)-8.7(hy)-303.1(is)-301.4(anot)-7.6(her)-302(indicat)-11.5(ion)-301(for)-307.8(which)-308.2(gosha-)]TJ
-.8991 -1.2007 TD
[(jinki-gan)-314.8(appears)-309.8(help)-7.6(ful.)-309(In)-305.1(an)-310.6(open)-306.4(trial)-311.8(of)-305.1(the)-308.4(formul)-9.1(a)-304.2(a)0(t)-307.7(a)]TJ
T*
[(dose)-375.9(of)-379.1(2.5)-172.6(g)-370.7(t.i)-7.4(.d.,)-377.5(neuropat)-8.7(hic)-376.7(symptom)-10.7(s)-371.8(improv)-7.1(ed)-378.9(in)-379.9(9/13)]TJ
T*
[(\(69%\))-289.3(patients)-298(with)-285.7(diab)-7.6(etic)-291(neuropat)-8.7(hy)-286.1(after)-292.9(three)-291(months.)]TJ
7.4718 0 0 6.641 554.3998 221.7826 Tm
(17)Tj
9.9626 0 0 9.9626 313.3416 205.3983 Tm
[(After)-568.2(was)-9.2(hout,)-569.6(7/13)-569.2(\(54%\))-573.9(such)-569.4(patients)-571.1(wor)-8.2(sened)-571.9(again)]TJ
T*
[(within)-398.1(two)-395.9(months.)-399.4(Th)-7(ere)-394.8(was)-401.8(a)-395.2(statistica)-12.1(lly)-394.8(signica)-9.9(nt)-391.3(im-)]TJ
T*
[(proveme)-8.7(nt)-214.8(in)-214.8(vibrat)-8.2(ory)-214.8(sense)-220.3(during)-219.9(gosha-jinki)-10.2(-gan)-217.4(treatme)-10.3(nt)]TJ
T*
[(compare)-10.5(d)-308.1(t)0(o)-305.9(basel)-11.3(ine.)-308.8(A)-312(group)-313.1(of)-310.8(116)-309.6(Japanese)-317.2(patient)-11.5(s)-309.2(with)]TJ
0 -1.195 TD
[(diabetes)-388.1(mell)-8.2(itus)-385.3(type)-383.2(2)-382(taking)-393.2(standard)-385.5(ther)-9.6(apies)-386.9(were)-388.1(ran-)]TJ
0 -1.2007 TD
[(domize)-8.7(d)-302.4(t)0(o)-311.6(take)-311(either)-311.6(gosha-)-9.5(jinki-gan)-314.8(granules)-311.5(2.5)-172.6(g)-308.1(t.i.d.)-304.9(or)]TJ
T*
[(no)-217.8(addi)-7.6(tional)-225.2(treatme)-10.3(nt)-220.5(for)-216.8(v)-6.4(e)-218.8(years.)]TJ
7.4718 0 0 6.641 462.5007 138.1039 Tm
(18)Tj
9.9626 0 0 9.9626 472.1951 133.6818 Tm
[(In)-219.7(this)-220.3(open)-226.8(trial,)-221.1(there)]TJ
-15.9449 -1.2007 TD
[(was)-396.2(a)-389.5(signica)-9.9(nt)-391.2(decr)-8.6(ease)-396.6(in)-391.3(deterioriat)-11.7(ion)-392(of)-390.5(onset)-396.5(of)-396.2(neu-)]TJ
T*
[(ropathy)-672(wi)-8.2(th)-670.1(gosha-jinki)-10.2(-gan)-672.6(compare)-10.5(d)-666.6(t)0(o)-675.8(n)0(o)-667.3(addi)-7.6(tional)]TJ
T*
[(treatme)-10.3(nt.)-289.2(A)-294.9(double-bl)-10.5(ind,)-290(rando)-7.6(mized)-298.2(trial)-294.7(is)-290(neede)-9.2(d)-291(t)0(o)-294.5(con-)]TJ
T*
[(rm)-280.2(whe)-8(ther)-282.7(these)-284.5(resu)-8(lts)-282.2(are)-286.7(accurate.)]TJ
.8991 -1.2007 TD
[(Only)-379.6(later)-9.2(al)-376(roots)-379.6(\(not)-383.4(the)-376.7(central)-388.1(tap)-376.7(root\))-380.4(of)-379.1(aconite)-386.1(are)]TJ
-.8991 -1.195 TD
[(recommend)-9.9(ed)-185.4(for)-188.3(use,)-182.1(and)-186.2(only)-187.9(after)-190.5(being)-184.8(cooked)-190.2(for)-182.6(on)-7.2(e)-179(hou)-8(r)]TJ
0 -1.2007 TD
[(and)-226(then)-229.5(dried.)-232.6(This)-228.7(largely)-232.7(elimina)-9.3(tes)-224.3(the)-228.8(C19)-7(-norditer)-8.7(penoid)]TJ
ET
38.608 325.814 .62363 388.46 re
f
281.083 325.814 .62363 388.46 re
f
38.608 713.707 243.099 .56689 re
f
38.608 325.814 243.099 .56696 re
f
q
227.969 0 0 372.926 46.375 333.581 cm
/Im1 Do
Q
BT
/F10 1 Tf
8.4682 0 0 8.4682 35.8866 311.5842 Tm
[(Figure)-418.6(1.)]TJ
/F11 1 Tf
4.9274 0 TD
[(Aconitum)-419.8(columbianum)]TJ
/F10 1 Tf
10.7317 0 TD
[(herb)-421.2(and)-414.6(root)-421.8(\(inset\).)-421.9(Drawing)]TJ
-15.6591 -1.0645 TD
[(by)-329.6(Meredith)-341.6(Hale)-330.2(and)-341(reprinted)-333.7(with)-335.4(permission.)]TJ
ET
/Cs8 cs 1 scn
313.568 37.814 287.66 .51022 re
f
BT
/F7 1 Tf
7.9702 0 0 7.9702 406.2613 25.9086 Tm
0 0 0 rg
[(MARY)-331.3(ANN)-333.9(LIEBERT)10.7(,)-337.2(INC.)]TJ
/F8 1 Tf
10.3425 .0996 TD
()Tj
/F7 1 Tf
.6758 -.0996 TD
[(VOL.)-326.8(23)-336.6(NO.)-325.5(6)]TJ
13.9476 0 0 13.9476 555.3069 21.9401 Tm
/Cs8 cs 1 scn
(247)Tj
ET
312.831 755.093 279.95 .51019 re
f
BT
7.9702 0 0 7.9702 352.6865 761.6124 Tm
0 0 0 rg
[(ALTERNAT)9.9(IVE)-334(AND)-333.3(COMPLEM)12.6(ENTARY)-326(THERAPIES)]TJ
/F8 1 Tf
19.7176 .0996 TD
()Tj
/F7 1 Tf
.8322 -.0996 TD
[(DECEMBE)10.9(R)-333.6(2017)]TJ
ET
endstream
endobj
39 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nlٳf͛6lٳfO9yH5T)9C(bAᐨ5{5X4MNe}qrľ9;ᇕ7-/5T4<*})VwB7>/lM;Zn#n)IdH]ֳeyY&ۥI$te
ʼnj ~dyeЃ݂TE-VZDk$)֟VOf\b5_CvC֗vF,(57<rk ߖ_ڐX66z}FԠzO7F,(6
?^
=
im$9'V/K_.XF842$HyŰڋqQGZÏΡyx֧( ޘTnWm?W<)&x+Xfz c-͛6lٳf͛6lٳf͛9BG~g[W^Wڴ1R[V3jZƙۅ%avB7"8֮E|.|͢k.moMH)]*
N5'|i
OO